“…For example, in the setting of chronic inflammation, ELAM-I is preferentially expressed on venules in the skin (Norris et al, 1991). Expression of ELAM-I's lymphocyte ligand, cutaneous lymphocyte-associated antigen (CLA), is largely limited to a skin-homing subset of memory/effector T-lymphocytes (Berg et al, 1991 (Moughal et al, 1992;Tonetti et al, 1994 sented by a cell that takes up and degrades it and displays the relevant immunogenic fragments in the context of MHC Class 11 products An antigen-presenting cell (APC) therefore must express MHC Class 11 antigens. It has been speculated that normally MHC Class 11 antigennegative cell types-including endothelial cells (De Waal et ci., 1983, Geppert andLipsky, 1985), astrocytes (Wong et ci., 1984), keratinocytes (Breathnach and Katz, 1983;Basham et cil., 1984), and fibroblasts (Pober et al, 1983;Geppertand Lipsky, 1985, Maureretal., 1985, 1987 Previous studies systematically examined APC function of MHC Class II-positive dermal fibroblasts which had been stimulated with IFN-y (Pober et cil, 1983, Geppert and Lipsky, 1985, Umetsu et al, 1985Maurer et cal., 1987).…”